Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

Author： Rofail Pierre Tadros Mariam Ywakim Riham Tadrous Mina Krug Allison Cosler Leon E

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.12, Iss.6, 2012-12, pp. : 699-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia

By Saloustros Emmanouil Tryfonidis Kostas Georgoulias Vassilis

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 851-863

Informa Healthcare

Access to resources Recommend Favorite

Lenograstim: A Review of its Use in Chemotherapy-Induced Neutropenia, for Acceleration of Neutrophil Recovery Following Haematopoietic Stem Cell Transplantation and in Peripheral Blood Stem Cell Mobilization

By Keating Gillian M.

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 679-707

Adis International

Access to resources Recommend Favorite

Administration of pegfilgrastim from the first cycle of chemotherapy reduces febrile neutropenia in elderly patients with solid tumours

Reactions Weekly, Vol. 1, Iss. 1053, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lenograstim: An Update of its Pharmacological Properties and Use in Chemotherapy-Induced Neutropenia and Related Clinical Settings

By Dunn C.J. Goa K.L.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 681-717

Adis International

Access to resources Recommend Favorite

Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia

By Esser M. Brunner H.

PharmacoEconomics, Vol. 21, Iss. 18, 2003-01 ,pp. : 1295-1313

Adis International

Access to resources Recommend Favorite